Copyright Reports & Markets. All rights reserved.

Global Hormonal Contraceptive Market 2020 by Company, Regions, Type and Application, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Hormonal Contraceptive Market Overview

    • 1.1 Product Overview and Scope of Hormonal Contraceptive
    • 1.2 Classification of Hormonal Contraceptive by Type
      • 1.2.1 Global Hormonal Contraceptive Revenue by Type: 2015 VS 2019 VS 2025
      • 1.2.2 Global Hormonal Contraceptive Revenue Market Share by Type in 2019
      • 1.2.3 Oral Contraceptive Pills
      • 1.2.4 Injectable Birth Control
      • 1.2.5 Emergency Contraceptive Pills
      • 1.2.6 Vaginal Rings
      • 1.2.7 Transdermal Patches
    • 1.3 Global Hormonal Contraceptive Market by Application
      • 1.3.1 Overview: Global Hormonal Contraceptive Revenue by Application: 2015 VS 2019 VS 2025
      • 1.3.2 Hospitals
      • 1.3.3 Household
      • 1.3.4 Clinics
    • 1.4 Global Hormonal Contraceptive Market by Regions
      • 1.4.1 Global Hormonal Contraceptive Market Size by Regions: 2015 VS 2019 VS 2025
      • 1.4.2 Global Market Size of Hormonal Contraceptive (2015-2025)
      • 1.4.3 North America (USA, Canada and Mexico) Hormonal Contraceptive Status and Prospect (2015-2025)
      • 1.4.4 Europe (Germany, France, UK, Russia and Italy) Hormonal Contraceptive Status and Prospect (2015-2025)
      • 1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Hormonal Contraceptive Status and Prospect (2015-2025)
      • 1.4.6 South America (Brazil, Argentina, Colombia) Hormonal Contraceptive Status and Prospect (2015-2025)
      • 1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Hormonal Contraceptive Status and Prospect (2015-2025)

    2 Company Profiles

    • 2.1 Ansell Limited
      • 2.1.1 Ansell Limited Details
      • 2.1.2 Ansell Limited Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.1.3 Ansell Limited SWOT Analysis
      • 2.1.4 Ansell Limited Product and Services
      • 2.1.5 Ansell Limited Hormonal Contraceptive Revenue, Gross Margin and Market Share (2018-2019)
    • 2.2 Pfizer
      • 2.2.1 Pfizer Details
      • 2.2.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.2.3 Pfizer SWOT Analysis
      • 2.2.4 Pfizer Product and Services
      • 2.2.5 Pfizer Hormonal Contraceptive Revenue, Gross Margin and Market Share (2018-2019)
    • 2.3 Johnson and Johnson
      • 2.3.1 Johnson and Johnson Details
      • 2.3.2 Johnson and Johnson Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.3.3 Johnson and Johnson SWOT Analysis
      • 2.3.4 Johnson and Johnson Product and Services
      • 2.3.5 Johnson and Johnson Hormonal Contraceptive Revenue, Gross Margin and Market Share (2018-2019)
    • 2.4 Bayer AG
      • 2.4.1 Bayer AG Details
      • 2.4.2 Bayer AG Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.4.3 Bayer AG SWOT Analysis
      • 2.4.4 Bayer AG Product and Services
      • 2.4.5 Bayer AG Hormonal Contraceptive Revenue, Gross Margin and Market Share (2018-2019)
    • 2.5 Mylan N.V.
      • 2.5.1 Mylan N.V. Details
      • 2.5.2 Mylan N.V. Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.5.3 Mylan N.V. SWOT Analysis
      • 2.5.4 Mylan N.V. Product and Services
      • 2.5.5 Mylan N.V. Hormonal Contraceptive Revenue, Gross Margin and Market Share (2018-2019)
    • 2.6 Church and Dwight Co
      • 2.6.1 Church and Dwight Co Details
      • 2.6.2 Church and Dwight Co Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.6.3 Church and Dwight Co SWOT Analysis
      • 2.6.4 Church and Dwight Co Product and Services
      • 2.6.5 Church and Dwight Co Hormonal Contraceptive Revenue, Gross Margin and Market Share (2018-2019)
    • 2.7 The Female Health Company
      • 2.7.1 The Female Health Company Details
      • 2.7.2 The Female Health Company Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.7.3 The Female Health Company SWOT Analysis
      • 2.7.4 The Female Health Company Product and Services
      • 2.7.5 The Female Health Company Hormonal Contraceptive Revenue, Gross Margin and Market Share (2018-2019)
    • 2.8 Merck and Co
      • 2.8.1 Merck and Co Details
      • 2.8.2 Merck and Co Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.8.3 Merck and Co SWOT Analysis
      • 2.8.4 Merck and Co Product and Services
      • 2.8.5 Merck and Co Hormonal Contraceptive Revenue, Gross Margin and Market Share (2018-2019)
    • 2.9 Mayer Laboratories
      • 2.9.1 Mayer Laboratories Details
      • 2.9.2 Mayer Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.9.3 Mayer Laboratories SWOT Analysis
      • 2.9.4 Mayer Laboratories Product and Services
      • 2.9.5 Mayer Laboratories Hormonal Contraceptive Revenue, Gross Margin and Market Share (2018-2019)
    • 2.10 Teva Pharmaceutical Industries
      • 2.10.1 Teva Pharmaceutical Industries Details
      • 2.10.2 Teva Pharmaceutical Industries Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.10.3 Teva Pharmaceutical Industries SWOT Analysis
      • 2.10.4 Teva Pharmaceutical Industries Product and Services
      • 2.10.5 Teva Pharmaceutical Industries Hormonal Contraceptive Revenue, Gross Margin and Market Share (2018-2019)
    • 2.11 Organon International
      • 2.11.1 Organon International Details
      • 2.11.2 Organon International Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.11.3 Organon International SWOT Analysis
      • 2.11.4 Organon International Product and Services
      • 2.11.5 Organon International Hormonal Contraceptive Revenue, Gross Margin and Market Share (2018-2019)
    • 2.12 Afaxys
      • 2.12.1 Afaxys Details
      • 2.12.2 Afaxys Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.12.3 Afaxys SWOT Analysis
      • 2.12.4 Afaxys Product and Services
      • 2.12.5 Afaxys Hormonal Contraceptive Revenue, Gross Margin and Market Share (2018-2019)

    3 Market Competition, by Players

    • 3.1 Global Hormonal Contraceptive Revenue and Share by Players (2015-2020)
    • 3.2 Market Concentration Rate
      • 3.2.1 Top 5 Hormonal Contraceptive Players Market Share
      • 3.2.2 Top 10 Hormonal Contraceptive Players Market Share
    • 3.3 Market Competition Trend

    4 Market Size by Regions

    • 4.1 Global Hormonal Contraceptive Revenue and Market Share by Regions
    • 4.2 North America Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
    • 4.3 Europe Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
    • 4.4 Asia-Pacific Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
    • 4.5 South America Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
    • 4.6 Middle East & Africa Hormonal Contraceptive Revenue and Growth Rate (2015-2020)

    5 North America Hormonal Contraceptive Revenue by Countries

    • 5.1 North America Hormonal Contraceptive Revenue by Countries (2015-2020)
    • 5.2 USA Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
    • 5.3 Canada Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
    • 5.4 Mexico Hormonal Contraceptive Revenue and Growth Rate (2015-2020)

    6 Europe Hormonal Contraceptive Revenue by Countries

    • 6.1 Europe Hormonal Contraceptive Revenue by Countries (2015-2020)
    • 6.2 Germany Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
    • 6.3 UK Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
    • 6.4 France Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
    • 6.5 Russia Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
    • 6.6 Italy Hormonal Contraceptive Revenue and Growth Rate (2015-2020)

    7 Asia-Pacific Hormonal Contraceptive Revenue by Countries

    • 7.1 Asia-Pacific Hormonal Contraceptive Revenue by Countries (2015-2020)
    • 7.2 China Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
    • 7.3 Japan Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
    • 7.4 Korea Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
    • 7.5 India Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
    • 7.6 Southeast Asia Hormonal Contraceptive Revenue and Growth Rate (2015-2020)

    8 South America Hormonal Contraceptive Revenue by Countries

    • 8.1 South America Hormonal Contraceptive Revenue by Countries (2015-2020)
    • 8.2 Brazil Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
    • 8.3 Argentina Hormonal Contraceptive Revenue and Growth Rate (2015-2020)

    9 Middle East & Africa Revenue Hormonal Contraceptive by Countries

    • 9.1 Middle East & Africa Hormonal Contraceptive Revenue by Countries (2015-2020)
    • 9.2 Saudi Arabia Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
    • 9.3 UAE Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
    • 9.4 Egypt Hormonal Contraceptive Revenue and Growth Rate (2015-2020)
    • 9.5 South Africa Hormonal Contraceptive Revenue and Growth Rate (2015-2020)

    10 Market Size Segment by Type

    • 10.1 Global Hormonal Contraceptive Revenue and Market Share by Type (2015-2020)
    • 10.2 Global Hormonal Contraceptive Market Forecast by Type (2019-2024)
    • 10.3 Oral Contraceptive Pills Revenue Growth Rate (2015-2025)
    • 10.4 Injectable Birth Control Revenue Growth Rate (2015-2025)
    • 10.5 Emergency Contraceptive Pills Revenue Growth Rate (2015-2025)
    • 10.6 Vaginal Rings Revenue Growth Rate (2015-2025)
    • 10.7 Transdermal Patches Revenue Growth Rate (2015-2025)

    11 Global Hormonal Contraceptive Market Segment by Application

    • 11.1 Global Hormonal Contraceptive Revenue Market Share by Application (2015-2020)
    • 11.2 Hormonal Contraceptive Market Forecast by Application (2019-2024)
    • 11.3 Hospitals Revenue Growth (2015-2020)
    • 11.4 Household Revenue Growth (2015-2020)
    • 11.5 Clinics Revenue Growth (2015-2020)

    12 Global Hormonal Contraceptive Market Size Forecast (2021-2025)

    • 12.1 Global Hormonal Contraceptive Market Size Forecast (2021-2025)
    • 12.2 Global Hormonal Contraceptive Market Forecast by Regions (2021-2025)
    • 12.3 North America Hormonal Contraceptive Revenue Market Forecast (2021-2025)
    • 12.4 Europe Hormonal Contraceptive Revenue Market Forecast (2021-2025)
    • 12.5 Asia-Pacific Hormonal Contraceptive Revenue Market Forecast (2021-2025)
    • 12.6 South America Hormonal Contraceptive Revenue Market Forecast (2021-2025)
    • 12.7 Middle East & Africa Hormonal Contraceptive Revenue Market Forecast (2021-2025)

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Methodology
      • 14.2 Data Source
      • 14.3 Disclaimer

      Market Overview
      The global Hormonal Contraceptive market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.7% in the forecast period of 2020 to 2025 and will expected to reach USD 20020 million by 2025, from USD 17990 million in 2019.

      The Hormonal Contraceptive market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

      Market segmentation
      Hormonal Contraceptive market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

      By Type, Hormonal Contraceptive market has been segmented into:
      Oral Contraceptive Pills
      Injectable Birth Control
      Emergency Contraceptive Pills
      Vaginal Rings
      Transdermal Patches

      By Application, Hormonal Contraceptive has been segmented into:
      Hospitals
      Household
      Clinics

      Regions and Countries Level Analysis
      Regional analysis is another highly comprehensive part of the research and analysis study of the global Hormonal Contraceptive market presented in the report. This section sheds light on the sales growth of different regional and country-level Hormonal Contraceptive markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Hormonal Contraceptive market.

      The report offers in-depth assessment of the growth and other aspects of the Hormonal Contraceptive market in important countries (regions), including:
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
      South America (Brazil, Argentina, Colombia)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Competitive Landscape and Hormonal Contraceptive Market Share Analysis
      Hormonal Contraceptive competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Hormonal Contraceptive sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Hormonal Contraceptive sales, revenue and market share for each player covered in this report.

      The major players covered in Hormonal Contraceptive are:
      Ansell Limited
      Pfizer
      Johnson and Johnson
      Bayer AG
      Mylan N.V.
      Church and Dwight Co
      The Female Health Company
      Merck and Co
      Mayer Laboratories
      Teva Pharmaceutical Industries
      Organon International
      Afaxys

      Buy now